Search hospitals
>
California
>
San Francisco
UCSF Medical Center-Mission Bay
Claim this profile
San Francisco, California 94158
Global Leader in Cancer
Global Leader in Solid Tumors
Conducts research for Brain Tumor
Conducts research for Neuroblastoma
Conducts research for Breast Cancer
382 reported clinical trials
50 medical researchers
Summary
UCSF Medical Center-Mission Bay is a medical facility located in San Francisco, California. This center is recognized for care of Cancer, Solid Tumors, Brain Tumor, Neuroblastoma, Breast Cancer and other specialties. UCSF Medical Center-Mission Bay is involved with conducting 382 clinical trials across 693 conditions. There are 50 research doctors associated with this hospital, such as Arun A. Rangaswami, Kieuhoa T. Vo, Jennifer G. Michlitsch, and Hope Rugo, MD.
Area of expertise
Cancer
UCSF Medical Center-Mission Bay has run 81 trials for Cancer. Some of their research focus areas include:
Solid Tumors
UCSF Medical Center-Mission Bay has run 51 trials for Solid Tumors. Some of their research focus areas include:
Top PIs
Arun A. Rangaswami
UCSF Medical Center-Mission Bay
8 years of reported clinical research
Kieuhoa T. Vo
UCSF Medical Center-Mission Bay
4 years of reported clinical research
Jennifer G. Michlitsch
UCSF Benioff Children's Hospital Oakland
8 years of reported clinical research
Hope Rugo, MD
University of California San Francisco
6 years of reported clinical research
Clinical Trials running at UCSF Medical Center-Mission Bay
Cancer
Prostate Cancer
Brain Tumor
Melanoma
Testicular cancer
Burkitt Lymphoma
Neuroblastoma
Lung Cancer
Childhood Leukemia
Pancreatic Cancer
Immunotherapy + Chemotherapy
for Sarcoma
This phase III trial compares the effect of immunotherapy (pembrolizumab) plus chemotherapy (doxorubicin) to chemotherapy (doxorubicin) alone in treating patients with dedifferentiated liposarcoma (DDLPS), undifferentiated pleomorphic sarcoma (UPS) or a related poorly differentiated sarcoma that has spread from where it first started (primary site) to other places in the body (metastatic) or that cannot be removed by surgery (unresectable). Doxorubicin is in a class of medications called anthracyclines. Doxorubicin damages the cell's deoxyribonucleic acid (DNA) and may kill tumor cells. It also blocks a certain enzyme needed for cell division and DNA repair. A monoclonal antibody is a type of protein that can bind to certain targets in the body, such as molecules that cause the body to make an immune response (antigens). Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Adding immunotherapy (pembrolizumab) to the standard chemotherapy (doxorubicin) may help patients with metastatic or unresectable DDLPS, UPS or a related poorly differentiated sarcoma live longer without having disease progression.
Recruiting
2 awards
Phase 3
10 criteria
Chemotherapy
for Cancer
This phase III trial studies how well active surveillance help doctors to monitor subjects with low risk germ cell tumors for recurrence after their tumor is removed. When the germ cell tumor has spread outside of the organ in which it developed, it is considered metastatic. Chemotherapy drugs, such as bleomycin, carboplatin, etoposide, and cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. The trial studies whether carboplatin or cisplatin is the preferred chemotherapy to use in treating metastatic standard risk germ cell tumors.
Recruiting
2 awards
Phase 3
26 criteria
Letermovir
for Preventing Infection After Stem Cell Transplant in Blood Cancer
This phase III single arm trial determines whether taking prophylactic letermovir will reduce the likelihood of infection with cytomegalovirus (CMV) in children and adolescents after stem cell transplant compared to estimated rate of infection without prophylaxis. The treatments used to prepare for HCT reduce the body's natural infection-fighting ability and increase the likelihood of an infection with a virus called cytomegalovirus. "Prophylaxis" means to take a drug to prevent a disease or side effect. Letermovir is an antiviral drug that stops cytomegalovirus from multiplying and may prevent cytomegalovirus infection and make the disease less severe.
Recruiting
2 awards
Phase 3
5 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at UCSF Medical Center-Mission Bay?
UCSF Medical Center-Mission Bay is a medical facility located in San Francisco, California. This center is recognized for care of Cancer, Solid Tumors, Brain Tumor, Neuroblastoma, Breast Cancer and other specialties. UCSF Medical Center-Mission Bay is involved with conducting 382 clinical trials across 693 conditions. There are 50 research doctors associated with this hospital, such as Arun A. Rangaswami, Kieuhoa T. Vo, Jennifer G. Michlitsch, and Hope Rugo, MD.
Where is UCSF Medical Center-Mission Bay located?
**UCSF Medical Center-Mission Bay** - **Address:** 1825 4th Street, San Francisco, CA 94158. - **Directions:** Accessible via the Muni T-Third Street line. Exit at the UCSF Mission Bay Station on Third Street near 16th Street.
Who should I call to ask about financial aid or insurance network?
**UCSF Medical Center-Mission Bay Financial Assistance** - For assistance with your statement balance, payment plans, or to inquire about financial aid, contact the Patient Financial Services Office at (415) 353-3333 or (866) 433-4035. - For insurance-related questions, the Financial Counseling office is available at (415) 353-1966.
What insurance does UCSF Medical Center-Mission Bay accept?
UCSF Medical Center-Mission Bay accepts a variety of insurance plans, including PPOs, HMOs, Aetna Medicare Advantage Plans & Medicaid, HMO, POS, PPO, EPO, and several Medi-Cal plans. They have contracts with many health insurance companies, ensuring a broad coverage network. To determine your level of access to care at UCSF Health, please contact your health insurance company or employer's benefit manager.
What awards or recognition has UCSF Medical Center-Mission Bay received?
UCSF Medical Center-Mission Bay, located in San Francisco, California, is celebrated for its Magnet Recognition® for nursing excellence, showcasing over a decade of superior practices and patient care. The center is globally recognized for its pioneering research across multiple disciplines such as cardiovascular disease, neurological disorders, cancer, diabetes, genetic disorders, and immunological and infectious diseases.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.